222 related articles for article (PubMed ID: 24684733)
21. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
22. Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 β-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor α and insulin-like growth factor-1 receptor signaling pathways.
Hwang KA; Park MA; Kang NH; Yi BR; Hyun SH; Jeung EB; Choi KC
Toxicol Appl Pharmacol; 2013 Nov; 272(3):637-46. PubMed ID: 23933164
[TBL] [Abstract][Full Text] [Related]
23. Induced growth of BG-1 ovarian cancer cells by 17β-estradiol or various endocrine disrupting chemicals was reversed by resveratrol via downregulation of cell cycle progression.
Kang NH; Hwang KA; Kim TH; Hyun SH; Jeung EB; Choi KC
Mol Med Rep; 2012 Jul; 6(1):151-6. PubMed ID: 22552626
[TBL] [Abstract][Full Text] [Related]
24. Effects of 4-nonylphenol and bisphenol A on stimulation of cell growth via disruption of the transforming growth factor-β signaling pathway in ovarian cancer models.
Park MA; Choi KC
Chem Res Toxicol; 2014 Jan; 27(1):119-28. PubMed ID: 24308608
[TBL] [Abstract][Full Text] [Related]
25.
Yoon KS; Kwack SJ
J Toxicol Environ Health A; 2021 Oct; 84(19):800-809. PubMed ID: 34193021
[TBL] [Abstract][Full Text] [Related]
26. Estrogen receptor potentiates mTORC2 signaling in breast cancer cells by upregulating superoxide anions.
Kumari Kanchan R; Tripathi C; Singh Baghel K; Kumar Dwivedi S; Kumar B; Sanyal S; Sharma S; Mitra K; Garg V; Singh K; Sultana S; Kamal Tripathi R; Kumar Rath S; Bhadauria S
Free Radic Biol Med; 2012 Nov; 53(10):1929-41. PubMed ID: 23000059
[TBL] [Abstract][Full Text] [Related]
27. Benzophenone-1 and nonylphenol stimulated MCF-7 breast cancer growth by regulating cell cycle and metastasis-related genes via an estrogen receptor α-dependent pathway.
In SJ; Kim SH; Go RE; Hwang KA; Choi KC
J Toxicol Environ Health A; 2015; 78(8):492-505. PubMed ID: 25849766
[TBL] [Abstract][Full Text] [Related]
28. DDT mimicks estradiol stimulation of breast cancer cells to enter the cell cycle.
Dees C; Askari M; Foster JS; Ahamed S; Wimalasena J
Mol Carcinog; 1997 Feb; 18(2):107-14. PubMed ID: 9049186
[TBL] [Abstract][Full Text] [Related]
29. In vitro exposure to xenoestrogens induces growth hormone transcription and release via estrogen receptor-dependent pathways in rat pituitary GH3 cells.
Dang VH; Nguyen TH; Lee GS; Choi KC; Jeung EB
Steroids; 2009 Aug; 74(8):707-14. PubMed ID: 19463694
[TBL] [Abstract][Full Text] [Related]
30. Functional interaction of fibroblast growth factor-8, bone morphogenetic protein and estrogen receptor in breast cancer cell proliferation.
Masuda H; Otsuka F; Matsumoto Y; Takano M; Miyoshi T; Inagaki K; Shien T; Taira N; Makino H; Doihara H
Mol Cell Endocrinol; 2011 Aug; 343(1-2):7-17. PubMed ID: 21664418
[TBL] [Abstract][Full Text] [Related]
31. Genistein, a soy phytoestrogen, prevents the growth of BG-1 ovarian cancer cells induced by 17β-estradiol or bisphenol A via the inhibition of cell cycle progression.
Hwang KA; Kang NH; Yi BR; Lee HR; Park MA; Choi KC
Int J Oncol; 2013 Feb; 42(2):733-40. PubMed ID: 23229410
[TBL] [Abstract][Full Text] [Related]
32. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.
Thoennissen NH; O'Kelly J; Lu D; Iwanski GB; La DT; Abbassi S; Leiter A; Karlan B; Mehta R; Koeffler HP
Oncogene; 2010 Jan; 29(2):285-96. PubMed ID: 19855437
[TBL] [Abstract][Full Text] [Related]
33. Potential estrogenic activity of triclosan in the uterus of immature rats and rat pituitary GH3 cells.
Jung EM; An BS; Choi KC; Jeung EB
Toxicol Lett; 2012 Jan; 208(2):142-8. PubMed ID: 22062131
[TBL] [Abstract][Full Text] [Related]
34. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
35. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.
Chen J; Zeng J; Xin M; Huang W; Chen X
Horm Metab Res; 2011 Sep; 43(10):681-6. PubMed ID: 21932171
[TBL] [Abstract][Full Text] [Related]
36. Laccase-mediated transformations of endocrine disrupting chemicals abolish binding affinities to estrogen receptors and their estrogenic activity in zebrafish.
Torres-Duarte C; Viana MT; Vazquez-Duhalt R
Appl Biochem Biotechnol; 2012 Oct; 168(4):864-76. PubMed ID: 22941308
[TBL] [Abstract][Full Text] [Related]
37. Effects of 60-Hz fields, estradiol and xenoestrogens on human breast cancer cells.
Dees C; Garrett S; Henley D; Travis C
Radiat Res; 1996 Oct; 146(4):444-52. PubMed ID: 8927716
[TBL] [Abstract][Full Text] [Related]
38. Fenhexamid induces cancer growth and survival via estrogen receptor-dependent and PI3K-dependent pathways in breast cancer models.
Go RE; Kim CW; Lee SM; Lee HK; Choi KC
Food Chem Toxicol; 2021 Mar; 149():112000. PubMed ID: 33484789
[TBL] [Abstract][Full Text] [Related]
39. Neonatal exposure to p-tert-octylphenol causes abnormal expression of estrogen receptor alpha and subsequent alteration of cell proliferating activity in the developing Donryu rat uterus.
Yoshida M; Takenaka A; Katsuda S; Kurokawa Y; Maekawa A
Toxicol Pathol; 2002; 30(3):357-64. PubMed ID: 12051553
[TBL] [Abstract][Full Text] [Related]
40. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
